This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Methylation of p16 CpG Island And Malignant Transformation of Oral Epithelial Dysplasia

This study has been completed.
Information provided by (Responsible Party):
Dajun Deng, Peking University Identifier:
First received: February 2, 2009
Last updated: May 7, 2015
Last verified: May 2015
Oral epithelial dysplasia (OED) is one of the common precancerous lesions among Chinese adults. Biomarker is not available for detection of malignant potential of OED till now. p16 is an important tumor suppressor gene, which is inactivated frequently by methylation of CpG island in early stage of carcinogenesis. The present cohort study is to investigate whether p16 methylation is correlated with malignant transformation of OED.

Oral Epithelial Dysplasia, Mild or Moderate Grade

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Cohort Study on Prediction of Malignant Transformation of Oral Epithelial Dysplasia by p16 Methylation

Resource links provided by NLM:

Further study details as provided by Dajun Deng, Peking University:

Primary Outcome Measures:
  • The Number of Participants With Both Clinical and Histological Evidence of Malignant Transformation of Oral Epithelial Dysplasia [ Time Frame: from 3 months to 124 months ]
    The follow-up examination was carried out with a 3-month interval. Re-biopsy was done as clinically indicated, e.g. the lesion recurs or has tendency for malignant development. Pathologic diagnosis was made by at least two pathologists without the knowledge of baseline p16 methylation, based on the World Health Organization's criteria, at Peking University School of Stomatology. The number of participants with malignant transformation of oral dysplasia was calculated based on the number of participants with oral dysplasia progressed to carcinoma by the end of the trial in each cohorts.

Secondary Outcome Measures:
  • Cancer-free Survival Time for Patients With Oral Epithelial Dysplasia [ Time Frame: from 3 months to 124 months ]

Biospecimen Retention:   Samples With DNA
Tissue specimen are collected from outpatients and inpatients with oral leukoplakia by biopsy or surgical resection, fixed in neutral buffered formalin, and embedded in paraffin. Genomic DNA is extracted from tissue sections.

Enrollment: 93
Study Start Date: March 2005
Study Completion Date: October 2008
Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
patients with mild or moderate oral epithelial dysplasia containing methylated p16 CpG island.
patients with mild or moderate oral epithelial dysplasia NOT containing methylated p16 CpG island.

Detailed Description:
  • Background: Identification of malignant potential of oral epithelial dysplasia (OED) is virtually impossible on histopathological grounds alone. Inactivation of p16 gene by CpG methylation is an early frequent event during oral carcinogenesis. To investigate the predictive value of p16 methylation on malignant potential in OED, we carried out the prospective cohort study.
  • Methods: 101 patients with histologically confirmed mild or moderate OED were included in the present study. Baseline information of p16 methylation status of the OED lesions from 93 cases was obtained by methylation-specific PCR. Progression of the OEDs lesions was examined in 78 cases histologically during the 45.8 months double-blind followup survey (78/93). The association between p16 methylation and progression of OED was analyzed with SPSS13.0 software. All P-values were two-sided.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
101 patients with mild or moderate OED were selected from cases with oral leukoplakia, lichen planus, or chronic discoid erythematosus at Peking University School of Stomatology between 1995 and 2005. All of the patients with OED had been diagnosed pathologically by at least two senior pathologists using the criteria from '2005 WHO Classification System' (Gale et al, 2005). All cases involved primary lesions without any LASER, radiation therapy or chemotherapy. p16 methylation status of OED samples was analyzed with methylation-specific PCR combined with denatured high performance liquid chromatography (Sun et al, 2004). 93 eligible cases with p16-methylated or p16-unmethylated OED were enrolled into the cohort study.

Inclusion Criteria:

  • histological diagnosis of mild or moderate grade OED; and
  • enough amount of tissue sample from OED lesion for genomic DNA extraction; and
  • available of methylation status of p16 CpG island in the extracted DNA sample.

Exclusion Criteria:

  • histological diagnosis of severe grade OED or malignant disease; or
  • amount of tissue sample is not enough for preparation of genomic DNA (20ng); or
  • quality of the prepared DNA is not good enough for detection of p16 methylation; or
  • OED treatment history by LASER, radiotherapy, or chemotherapy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00835341

Department of Oral Medicine, Peking University School and Hospital of Stomatology
Beijing, China, 100081
Sponsors and Collaborators
Peking University
Study Director: Dajun Deng, MD Beijing Cancer Hospital/ Institue, Peking University School of Oncology
Principal Investigator: Hongwei Liu, MD, PhD Peking University School of Stomatology
  More Information

Additional Information:
Responsible Party: Dajun Deng, Professor and Department Director, Peking University Identifier: NCT00835341     History of Changes
Other Study ID Numbers: CPDHS-434
Study First Received: February 2, 2009
Results First Received: October 21, 2009
Last Updated: May 7, 2015

Keywords provided by Dajun Deng, Peking University:
oral epithelial dysplasia
p16 methylation
malignant transformation
oral squamous cell carcinoma

Additional relevant MeSH terms:
Carcinoma in Situ
Pathologic Processes
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms processed this record on June 23, 2017